Singapore firms ramp up Q1 buybacks past S$500M
In the first quarter of 2026, about 50 Singapore‑listed companies repurchased roughly S$560 million (≈ $414 million) of shares, up from S$330 million a year earlier. Singtel led the market with S$123 million (≈ $91 million) of buybacks, followed by OCBC at S$116 million and Keppel at S$94 million, together accounting for nearly three‑fifths of total spend.
Also developing:
State attorneys general, led by California’s Rob Bonta, have filed lawsuits to block the $6.2 billion Nexstar‑Tegna merger and are weighing a challenge to Paramount’s $110 billion bid for Warner Bros. Discovery. The moves come after the DOJ and FCC approved the deals, prompting a temporary restraining order and a potential court showdown that could reshape local TV ownership and national news competition.
Saks Global Enterprises has secured a $500 million financing commitment from its capital partners, positioning the luxury retailer to exit Chapter 11 bankruptcy this summer. The deal follows a $2.7 billion acquisition of Neiman Marcus that left the company $3.4 billion in debt and forced...
SPDR Gold Shares (GLD) offers low‑volatility, high‑liquidity exposure to physical gold, while iShares SLVP and Sprott SGDM deliver higher returns but greater drawdowns through mining equities. The contrast is prompting options traders to tailor strategies around each ETF’s risk‑return profile.
Goldman Sachs' premier brokerage division reported that hedge funds liquidated global equities in March at the fastest rate in 13 years, second‑fastest since the firm began tracking the metric in 2011. The sell‑off was sparked by a 17% jump in...
Tennessee’s Senate Finance Committee advanced SB 2040, a bill banning pharmacy‑benefit managers from owning pharmacies. State officials warn the measure could increase TennCare spending by $66 million, shifting costs to taxpayers and vulnerable patients. CFOs in health‑care will need to reassess budgeting...
Walmart announced a $10 hike to standard Sam's Club memberships and a $10 rise to its Plus tier, underscoring a shift toward higher‑margin revenue streams such as advertising and e‑commerce. The move comes as the retailer’s operating income rose 10.5%...

The episode examines the rapid expansion of private credit, now accounting for 15‑20% of the U.S. loan market, and the growing nervousness among banks and investors. Host highlights how private credit surged over 50% in loan growth during the past...

Current cash levels in a historical perspective, as per the BofA FMS. Feels like a good time to buy https://t.co/KoeTO5ThBC

Mastercard announced the acquisition of BVNK, a developer‑centric fintech that offers API‑driven card issuance and rapid payment‑flow integration. The deal equips Mastercard with embedded‑finance tools designed to slash merchant onboarding times and streamline consumer checkout experiences. By folding BVNK’s agile...
MP Materials recorded a $149.4 million operating loss for 2025, extending a ten‑quarter streak of negative margins, while USA Rare Earth’s shares slid 19.9% in March despite positive operational news. The twin setbacks underscore financial pressure on the domestic rare‑earth supply...
The Questa Hydrogen Project in New Mexico secured $231 million to build a 50 MW solar array for long‑duration hydrogen storage, while the Villeta Green Fertilizer Project in Paraguay received a $50 million junior loan that will mobilise over $500 million for the world’s first...
Wall Street Zen upgraded Alphabet (GOOGL) from hold to buy, joining Raymond James, Wolfe Research and others in raising price targets. At the same time, Wedge Capital Management slashed its Alphabet position by 27.3%, selling nearly 79,000 shares worth $66 million, underscoring...
Roku reported fourth‑quarter revenue of $1.39 billion, up 16% year over year, while its platform segment grew 18% to $1.22 billion. Despite the top‑line gains, the company posted a device gross margin of –23.3% and its stock fell sharply, prompting investors to...
Rosen Law Firm has filed a securities‑fraud class action against gene‑therapy company REGENXBIO, alleging false statements about its RGX-111 candidate. Investors who bought shares between Feb. 9 2022 and Jan. 27 2026 must file by April 14 2026 to serve as lead plaintiff.
Since questions about private credit are so popular today, I had a segment with Danny about the topic: